| General Information of Drug Metabolite (DM) (ID: DM001319) |
| DM Name |
KMD-3241 glucuronide
|
|
|
|
|
|
|
|
| Full List of Drug-Metabolizing Enzyme (DME) Related to This DM |
| DME(s) Producing This DM through Metabolism |
| DME Name |
DME ID |
Reactant |
Reaction |
Related Drug |
REF |
|
UDP-glucuronosyltransferase 2B7 (UGT2B7)
|
DME0040
|
| Conjugation - Glucuronidation |
Silodosin
|
[1] |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Full List of Drug(s) That Produce This DM By Metabolism |
| Silodosin |
DR1482
|
Approved |
Prostatic hyperplasia |
|
|
| References |
| 1 |
In vivo metabolic investigation of silodosin using UHPLC-QTOF-MS/MS and in silico toxicological screening of its metabolites J Mass Spectrom. 2016 Oct;51(10):867-882. doi: 10.1002/jms.3795.
|
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.
